Delivery Order SPE2DB22D3102-SPE2DB25FL2HP
- Not listed
- The Defense Logistics Agency awarded a $5,568.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies vaccine vials. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,568.75 for IMOVAX Rabies Vaccine vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials on September 10, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $2,286.87 and has an ultimate completion date of September 11, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,895.75 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. The contract, which was competitively awarded with no set-aside designation, is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of IMOVAX Rabies Vaccine Vials, with a ceiling value of $4,133.00 and an ultimate completion date of June 9, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,500.75 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on April 22, 2025, for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed-price delivery order, valued at $2,673.00, is scheduled for completion by April 23, 2025, and will be performed at the awardee's Conshohocken facility. The award represents a non-set-aside, competitively awarded contract typical of...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.75 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine vials, with a completion date of September 9, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.25 to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine vials on August 28, 2025, with a completion date of August 29, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,017.00 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine vials on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2HPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,227.50 delivery order for IMOVAX Rabies Vaccine vials under a firm fixed-price contract type. This non-set-aside award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in supplying pharmaceutical products, vaccines, and medical supplies to military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of a vast range of medications, vaccines, and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for rabies vaccine vials aligns with AmerisourceBergen's established portfolio of federal medical supply contracts awarded through open competition with the DLA and demonstrates the company's capability to fulfill specialized vaccine procurement requirements for defense healthcare operations.